These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 22218226)
1. Hepatitis C virus and atherosclerosis in a close and dangerous liaison. Vassalle C Atherosclerosis; 2012 Apr; 221(2):319-20. PubMed ID: 22218226 [No Abstract] [Full Text] [Related]
2. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985 [TBL] [Abstract][Full Text] [Related]
3. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Kozakova M; Palombo C; Eng MP; Dekker J; Flyvbjerg A; Mitrakou A; Gastaldelli A; Ferrannini E; Hepatology; 2012 May; 55(5):1406-15. PubMed ID: 22334565 [TBL] [Abstract][Full Text] [Related]
4. Gender-based differences in the relationship between fatty liver disease and atherosclerosis. Kim HJ; Lim CW; Lee JH; Park HB; Suh Y; Cho YH; Choi TY; Hwang ES; Cho DK Cardiovasc J Afr; 2016 Sep/Oct 23; 27(5):281-286. PubMed ID: 26972662 [TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes. Guo K; Zhang L; Lu J; Yu H; Wu M; Bao Y; Chen H; Jia W J Diabetes Complications; 2017 Jan; 31(1):80-85. PubMed ID: 27742552 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364 [TBL] [Abstract][Full Text] [Related]
7. HIV, Cocaine Use, and Hepatitis C Virus: A Triad of Nontraditional Risk Factors for Subclinical Cardiovascular Disease. Lucas GM; Atta MG; Fine DM; McFall AM; Estrella MM; Zook K; Stein JH Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2100-7. PubMed ID: 27609369 [TBL] [Abstract][Full Text] [Related]
8. Carotid plaque in absence of traditional and non-traditional cardiovascular risk factors. Oh PC; Han SH; Kim JS; Park JB; Koh KK Int J Cardiol; 2010 Sep; 143(3):e57-9. PubMed ID: 19324438 [TBL] [Abstract][Full Text] [Related]
9. Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Targher G Hepatology; 2005 Oct; 42(4):974-5; discussion 975. PubMed ID: 16175589 [No Abstract] [Full Text] [Related]
10. PNPLA3 I148M variant as a risk factor for carotid atherosclerosis in chronic hepatitis C. Zampino R; Florio A; Coppola N; Cirillo G; Macera M; Marrone A; Adinolfi LE; Del Giudice EM Int J Cardiol; 2014 Mar; 172(1):291-2. PubMed ID: 24461483 [No Abstract] [Full Text] [Related]
12. The risk association between experimental portal hypertension and an aortic atherosclerosis-like disease. De las Heras N; Aller MA; Arias J; Lahera V Hepatology; 2013 Jan; 57(1):421-2. PubMed ID: 22730048 [No Abstract] [Full Text] [Related]
13. Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort. Setiawan VW; Porcel J; Wei P; Stram DO; Noureddin N; Lu SC; Le Marchand L; Noureddin M Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1305-1307. PubMed ID: 28300689 [No Abstract] [Full Text] [Related]
14. Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. Petta S; Marrone O; Torres D; Buttacavoli M; Cammà C; Di Marco V; Licata A; Lo Bue A; Parrinello G; Pinto A; Salvaggio A; Tuttolomondo A; Craxì A; Bonsignore MR PLoS One; 2015; 10(12):e0142210. PubMed ID: 26672595 [TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B associated with hepatic steatosis, insulin resistance, necroinflammation and fibrosis. Yilmaz B; Koklu S; Buyukbayram H; Yalçin K; Korkmaz U; Posul E; Can G; Kurt M Afr Health Sci; 2015 Sep; 15(3):714-8. PubMed ID: 26957957 [TBL] [Abstract][Full Text] [Related]
16. [Clinical applicability of the framingham 30-year risk score. Usefulness in cardiovascular risk stratification and the diagnosis of carotid atherosclerotic plaque]. Masson W; Siniawski D; Krauss J; Cagide A Rev Esp Cardiol; 2011 Apr; 64(4):305-11. PubMed ID: 21377779 [TBL] [Abstract][Full Text] [Related]
17. No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. Coracina A; Gaiani S; Cosma A; Pellizzari P; Pizzi C; de Kreutzenberg S; Cecchet D; Sacerdoti D; Tessari P Nutr Metab Cardiovasc Dis; 2012 May; 22(5):e11-2. PubMed ID: 22397876 [No Abstract] [Full Text] [Related]
18. Elevated Serum Gamma-glutamyl Transpeptidase Levels and Fatty Liver Strongly Predict the Presence of Carotid Plaque. Toshikuni N; Asaji T; Nakanishi Y; Nagasawa SY; Uenishi H; Tsutsumi M J Atheroscler Thromb; 2015; 22(10):1051-60. PubMed ID: 25891209 [TBL] [Abstract][Full Text] [Related]
19. Enhanced carotid plaque on contrast-enhanced ultrasound is associated with plaque instability and rupture. Matsumoto N; Kimura K; Uno M; Sakai K; Sadahira Y; Nishimura H Int J Stroke; 2012 Oct; 7(7):E12. PubMed ID: 22989396 [No Abstract] [Full Text] [Related]
20. Stroke: cause and effect--seek and ye shall find. Moody A JACC Cardiovasc Imaging; 2012 Apr; 5(4):406-8. PubMed ID: 22498330 [No Abstract] [Full Text] [Related] [Next] [New Search]